USA v. SCHESSEL

Track this case

Case Number:

2:22-cr-00374

Court:

New Jersey

Nature of Suit:

Judge:

Esther Salas

Firms

  1. April 23, 2024

    Feds Seek To Bar Fox Rothschild Atty From Fraud Retrial

    The government is seeking to bar a Fox Rothschild LLP partner from testifying as an expert witness for the defense in the retrial of a federal securities fraud case that ended in a dramatic mistrial after a lone juror told the judge that he disagreed with the guilty verdict the forewoman had delivered to the court.

  2. December 20, 2023

    Feds Will Retry Securities Fraud Case Over COVID-19 Test Kits

    The retrial of a federal securities fraud case that ended in a dramatic mistrial after a lone juror told the judge that he disagreed with the guilty verdict the forewoman had delivered to the court has been scheduled for May 29, according to the court file.

  3. December 06, 2023

    How One Word Turned A Guilty Verdict Into A Mistrial

    The occasional mistrial in a fact-heavy criminal case is a job hazard prosecutors and defense attorneys have come to expect, but a lone juror's sudden sabotage of a guilty verdict last week was a first to many in the Newark, New Jersey, federal courthouse.

  4. December 01, 2023

    Guilty Verdict Turns Into Mistrial In Securities Fraud Case

    A juror's declaration disagreeing with his colleagues' initially reported guilty verdict resulted in a mistrial on Friday in the New Jersey case of a former CEO accused of duping investors into thinking he had a viable contract to deliver tens of millions of COVID-19 test kits.

  5. November 28, 2023

    COVID Test Kit Fraud Case Is A Matter Of Timing, Jurors Told

    It all boils down to who knew what when, jurors in New Jersey federal court were told Tuesday regarding whether the ex-head of a struggling company exploited the COVID-19 pandemic to dupe investors or was the victim of a legitimate business deal gone bad.

  6. November 02, 2023

    Ex-CEO Duped Investors Over COVID Tests, Jurors Told

    The former head of a struggling company exploited the COVID-19 pandemic to dupe investors into thinking he had a viable contract to deliver millions of test kits, a New Jersey federal jury heard Thursday.